John G. Aunins

CTO and EVP of Bioprocess Dev., Seres Therapeutics, Inc.

Companies

Seres Therapeutics, Inc.CTO and EVP of Bioprocess Dev. Jun 25, 2015 to Jan 31, 2020¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSeres Therapeutics, Inc., CTO and EVP of Bioprocess Dev.